Hugues le Bret
Direktor/Vorstandsmitglied bei XILAM ANIMATION
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Stéphane Thiroloix | M | - |
Algotherapeutix SAS
 Algotherapeutix SAS Medical SpecialtiesHealth Technology AlgoTherapeutix SAS is a clinical-stage biotechnology company based in Suresnes, France. The French company is focused on developing targeted, first-in-class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a proprietary topical formulation of amitriptyline that targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. The company is currently recruiting patients for a phase II clinical trial of 240 patients for chemotherapy-induced neuropathic pain and a phase II proof of concept trial for erythromelalgia. AlgoTherapeutix has secured FDA fast track development status and orphan drug designation in both the US and EU. AlgoTherapeutix has raised EUR 35 million to date and has a consortium of investors, including Relyens Innovation Santé/Turenne Capital, UI Investissement, and angel investors. The company was founded in 2018 by Olivier Jean Bohuon and Stéphane Thiroloix, with Stéphane Thiroloix serving as the CEO since 2018. | 6 Jahre |
| Etienne Bizot | M | 62 |
Société Jacques Bollinger SA
 Société Jacques Bollinger SA Beverages: AlcoholicConsumer Non-Durables Société Jacques Bollinger SA manufactures and supplies distilled alcoholic and wine products. The company was founded in 1986 and is headquartered in Paris, France. | - |
| Junaid Subhan | M | - |
Portage Ventures
 Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 5 Jahre |
| Marc du Pontavice | M | 58 | 25 Jahre | |
| François-Xavier de Maistre | M | - | 24 Jahre | |
| Edmund Harrigan | M | 71 |
Algotherapeutix SAS
Algotherapeutix SAS Medical SpecialtiesHealth Technology AlgoTherapeutix SAS is a clinical-stage biotechnology company based in Suresnes, France. The French company is focused on developing targeted, first-in-class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a proprietary topical formulation of amitriptyline that targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. The company is currently recruiting patients for a phase II clinical trial of 240 patients for chemotherapy-induced neuropathic pain and a phase II proof of concept trial for erythromelalgia. AlgoTherapeutix has secured FDA fast track development status and orphan drug designation in both the US and EU. AlgoTherapeutix has raised EUR 35 million to date and has a consortium of investors, including Relyens Innovation Santé/Turenne Capital, UI Investissement, and angel investors. The company was founded in 2018 by Olivier Jean Bohuon and Stéphane Thiroloix, with Stéphane Thiroloix serving as the CEO since 2018. | 3 Jahre |
| Lai Ricky | M | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 7 Jahre |
| Kris Hansen | M | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 7 Jahre |
| Jake Bodanis | M | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 5 Jahre |
| Dorothee Lanchier | M | - | - | |
| Paul Desmarais | M | 41 |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 8 Jahre |
| Pierre Monfort | M | - | 16 Jahre | |
| Eric de Poncins | M | 62 |
Société Jacques Bollinger SA
Société Jacques Bollinger SA Beverages: AlcoholicConsumer Non-Durables Société Jacques Bollinger SA manufactures and supplies distilled alcoholic and wine products. The company was founded in 1986 and is headquartered in Paris, France. | 8 Jahre |
| Christophe Dandois | M | - |
Leocare SAS
 Leocare SAS Packaged SoftwareTechnology Services Leocare SAS is a French insurance company that offers online and commitment-free insurance for cars, motorcycles, homes, and smartphones. The company is based in Paris, France and was founded in 2017 by Noureddine Bekrar and Christophe Dandois. Customers can receive a quote in less than a minute and purchase insurance in four minutes. Leocare also provides customer service to assist with any questions. Leocare is committed to protecting the privacy of its customers and complying with all applicable data protection regulations. | 7 Jahre |
| Yann Gérardin | M | 62 | 6 Jahre | |
| Pierre Chapon | M | - |
FINSPOT SAS
 FINSPOT SAS Finance/Rental/LeasingFinance FINSPOT SAS provides mortgage brokerage services. It also provides real estate property services. The company was founded by Renaud Pestre and Pierre Chapon in November 2016 and is headquartered in Saint-Ouen, France. | 8 Jahre |
| Scott A. Byrd | M | 54 |
Algotherapeutix SAS
Algotherapeutix SAS Medical SpecialtiesHealth Technology AlgoTherapeutix SAS is a clinical-stage biotechnology company based in Suresnes, France. The French company is focused on developing targeted, first-in-class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a proprietary topical formulation of amitriptyline that targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. The company is currently recruiting patients for a phase II clinical trial of 240 patients for chemotherapy-induced neuropathic pain and a phase II proof of concept trial for erythromelalgia. AlgoTherapeutix has secured FDA fast track development status and orphan drug designation in both the US and EU. AlgoTherapeutix has raised EUR 35 million to date and has a consortium of investors, including Relyens Innovation Santé/Turenne Capital, UI Investissement, and angel investors. The company was founded in 2018 by Olivier Jean Bohuon and Stéphane Thiroloix, with Stéphane Thiroloix serving as the CEO since 2018. | - |
| Ronald Close | M | 65 |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | - |
| Jean-Bernard Levy | M | 69 | 15 Jahre | |
| Adam Felesky | M | 48 |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 8 Jahre |
| Robin Tessier | M | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 2 Jahre |
| Pierre-Emmanuel Lawde Lariston de Boubers | M | - |
Société Jacques Bollinger SA
Société Jacques Bollinger SA Beverages: AlcoholicConsumer Non-Durables Société Jacques Bollinger SA manufactures and supplies distilled alcoholic and wine products. The company was founded in 1986 and is headquartered in Paris, France. | - |
| Gregoire Viat | M | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 3 Jahre |
| Ivan Koparan | M | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | - |
| Johan Praud | M | 38 | 19 Jahre | |
| Bertrand Cozzarolo | M | - | 20 Jahre | |
| Mickias Hailu | M | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 3 Jahre |
| Leo Liu | M | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 3 Jahre |
| Victoire de Lavigne | F | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 3 Jahre |
| Peter Hancock | M | 65 |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 5 Jahre |
| Natalie Heckel | F | - | 3 Jahre | |
| Ben Harrison | M | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 6 Jahre |
| Sinath Kim | F | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 6 Jahre |
| Valentin Moriceau | M | - | 2 Jahre | |
| Amer Javed | M | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | - |
| Eric de Montaigne de Poncins | M | - |
Société Jacques Bollinger SA
Société Jacques Bollinger SA Beverages: AlcoholicConsumer Non-Durables Société Jacques Bollinger SA manufactures and supplies distilled alcoholic and wine products. The company was founded in 1986 and is headquartered in Paris, France. | - |
| Jamess Forrest | M | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 5 Jahre |
| Nicolas Duboys de Labarre | M | - |
Smile & Pay SAS
 Smile & Pay SAS Packaged SoftwareTechnology Services Smile & Pay SAS develops software solutions for merchants. It develops software applications for merchants that accepts credit card payments. The firm also offers nomadic activities such as mobile commerce, handicrafts and personal assistance. The company was founded by Benoît Delestre and is headquartered in Paris, France. | 5 Jahre |
| Hardeep Brar | F | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 2 Jahre |
| Brendan Callaghan | M | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | - |
| Amanda Gaiotti | F | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 4 Jahre |
| Jane Jing | F | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 3 Jahre |
| Joseph Lau | M | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 5 Jahre |
| Eliza Pong | F | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 3 Jahre |
| Juliette Souliman | F | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 2 Jahre |
| Guillaume Jallot | M | - | - | |
| Hubert Moreau | M | - |
Société Jacques Bollinger SA
Société Jacques Bollinger SA Beverages: AlcoholicConsumer Non-Durables Société Jacques Bollinger SA manufactures and supplies distilled alcoholic and wine products. The company was founded in 1986 and is headquartered in Paris, France. | - |
| Sacha Haque | M | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 7 Jahre |
| George Hutton | M | 69 |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | - |
| Carina Doshi | F | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 3 Jahre |
| Thibaut Roulon | M | - |
Algotherapeutix SAS
Algotherapeutix SAS Medical SpecialtiesHealth Technology AlgoTherapeutix SAS is a clinical-stage biotechnology company based in Suresnes, France. The French company is focused on developing targeted, first-in-class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a proprietary topical formulation of amitriptyline that targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. The company is currently recruiting patients for a phase II clinical trial of 240 patients for chemotherapy-induced neuropathic pain and a phase II proof of concept trial for erythromelalgia. AlgoTherapeutix has secured FDA fast track development status and orphan drug designation in both the US and EU. AlgoTherapeutix has raised EUR 35 million to date and has a consortium of investors, including Relyens Innovation Santé/Turenne Capital, UI Investissement, and angel investors. The company was founded in 2018 by Olivier Jean Bohuon and Stéphane Thiroloix, with Stéphane Thiroloix serving as the CEO since 2018. | - |
| Alix de Maistre | M | - | 24 Jahre | |
| Mélanie Biessy | F | 52 | 7 Jahre | |
| Richard Reiner | M | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 5 Jahre |
| Laurent Goutard | M | 63 | 15 Jahre | |
| Laetitia Maurel | F | - | 24 Jahre | |
| Karine Allouis | F | - | - | |
| Daniel J. Ballen | M | 41 |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 2 Jahre |
| Marshall Lux | M | 64 |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 3 Jahre |
| François Bloch | M | 57 | 15 Jahre | |
| Claire Poulard | F | - |
Algotherapeutix SAS
Algotherapeutix SAS Medical SpecialtiesHealth Technology AlgoTherapeutix SAS is a clinical-stage biotechnology company based in Suresnes, France. The French company is focused on developing targeted, first-in-class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a proprietary topical formulation of amitriptyline that targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. The company is currently recruiting patients for a phase II clinical trial of 240 patients for chemotherapy-induced neuropathic pain and a phase II proof of concept trial for erythromelalgia. AlgoTherapeutix has secured FDA fast track development status and orphan drug designation in both the US and EU. AlgoTherapeutix has raised EUR 35 million to date and has a consortium of investors, including Relyens Innovation Santé/Turenne Capital, UI Investissement, and angel investors. The company was founded in 2018 by Olivier Jean Bohuon and Stéphane Thiroloix, with Stéphane Thiroloix serving as the CEO since 2018. | - |
| Cathia Lawson-Hall | F | 52 | 25 Jahre | |
| Ron Hirson | M | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | - |
| Hélène-Marie Falchier | F | 50 |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 5 Jahre |
| Victoire de Lavigne | F | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 3 Jahre |
| Stuart Harvey | M | 62 |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | - |
| Sharon MacLeod | F | 54 |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 5 Jahre |
| Steven Freiberg | M | 67 |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | - |
| Asiff Hirji | M | 57 |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | - |
| Karel Vuong | M | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | - |
| Stephanie Choo | F | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | - |
| Stephan Klee | M | 50 |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 6 Jahre |
| Hugues Epaillard | M | 57 | 6 Jahre | |
| Gonzague Villedey | M | - |
Société Jacques Bollinger SA
Société Jacques Bollinger SA Beverages: AlcoholicConsumer Non-Durables Société Jacques Bollinger SA manufactures and supplies distilled alcoholic and wine products. The company was founded in 1986 and is headquartered in Paris, France. | - |
| Greg Fleming | M | 61 |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | - |
| Timothy Tham | M | - |
Portage Ventures
Portage Ventures Investment ManagersFinance Portag3 Ventures (Portag3 Ventures) is a venture capital subsidiary of Sagard Private Equity founded in 2015 by Paul Guy Desmarais III and Adam Felesky. The firm is headquartered in Toronto, Canada. | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Michel Cicurel | M | 76 | 12 Jahre | |
| Jean-Martin Folz | M | 77 | 8 Jahre | |
| David Halkyard | M | - | 12 Jahre | |
| Romain Hirschmann | M | - | - | |
| Patrick Caetano | M | - | - | |
| William Kadouch-Chassaing | M | 54 | 14 Jahre | |
| Philippe Laurent Heim | M | 56 | 13 Jahre | |
| Guillaume May | M | - | 17 Jahre | |
| Katell Lardeux | F | - | - | |
| Emmanuelle Chabord | F | - | - | |
| Nathalie Rachou | F | 67 | 12 Jahre | |
| Patrick-André Suet | M | 70 | - | |
| Laurence Parisot | F | 64 | 12 Jahre | |
| Gianemilio Osculati | M | 77 | - | |
| Élisabeth Lulin | F | 58 | 10 Jahre | |
| Didier Valet | M | 56 | 15 Jahre | |
| Robert Castaigne | M | 78 | 10 Jahre | |
| Hervé Saint-Sauveur | M | 79 | 29 Jahre | |
| Vincent Taupin | M | 65 | 11 Jahre | |
| Olivier Jean Bohuon | M | 65 |
Algotherapeutix SAS
Algotherapeutix SAS Medical SpecialtiesHealth Technology AlgoTherapeutix SAS is a clinical-stage biotechnology company based in Suresnes, France. The French company is focused on developing targeted, first-in-class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a proprietary topical formulation of amitriptyline that targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. The company is currently recruiting patients for a phase II clinical trial of 240 patients for chemotherapy-induced neuropathic pain and a phase II proof of concept trial for erythromelalgia. AlgoTherapeutix has secured FDA fast track development status and orphan drug designation in both the US and EU. AlgoTherapeutix has raised EUR 35 million to date and has a consortium of investors, including Relyens Innovation Santé/Turenne Capital, UI Investissement, and angel investors. The company was founded in 2018 by Olivier Jean Bohuon and Stéphane Thiroloix, with Stéphane Thiroloix serving as the CEO since 2018. | 6 Jahre |
| Inès-Claire Mercereau | F | - | - | |
| Jean Azéma | M | 71 | 8 Jahre | |
| Laurent Droin | M | - | 9 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Frankreich | 56 | 56,57% |
| Kanada | 43 | 43,43% |
| Italien | 0 | -.--% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Hugues le Bret
- Persönliches Netzwerk
